an investigation of primary molar vital pulp therapy
DESCRIPTION
Estudio comparativo que demuestra la eficacia clinica de la dilución de la quinta parte del formocresol.TRANSCRIPT
BRITISH DENTAL JOURNAL, VOLUME 188, NO. 1, JANUARY 8 2000 25
SUMMARIESpediatric dentistry
ObjectiveTo compare the clinical and radiological outcomes following twodifferent, single visit vital pulp therapy techniques, in cariouslyexposed primary molar teeth.
SettingA paediatric dental clinic within the Dental Hospital, Newcastleupon Tyne, UK.
SubjectsFifty two child patients were sequentially enrolled in the clinicalinvestigation, 26 males and 26 females with an age range of 3.3–12.5years. Primary molar teeth requiring vital pulp therapy wererandomly allocated to either the formocresol group (F) or the calciumhydroxide group (C). The total number of teeth treated was 84.
DesignRecruitment was on the basis of strict inclusion criteria. Coronalpulp amputation was prescribed only in teeth with vital,cariously-exposed pulp tissue. Treatment was undertakenbetween October 1994 and December 1996. All cases werereviewed using predefined clinical and radiological criteria. Thestatistical tests used were logistic regression of a triple nested datastructure, chi-squared analysis of equality of treatment andprobability of success with relation to subject age.
ResultsEighty four cariously-exposed primary molars required vital pulptherapy. Forty six (55%) teeth were included in the F group and 38(45%) allocated to the C group. Five teeth were lost to follow-up,leaving 79 teeth: forty four (56%) in group F and 35 (44%) ingroup C. Eighty four per cent (37/44) of teeth treated with
Comment The use of formocresol in paediatricdentistry has caused concern for may years.In 1980 Pashley et al. reported theirfindings that formocresol is absorbed anddistributed rapidly and widely throughoutthe body within minutes of being placedon a pulpotomy site.1 In 1981 Lewis andChestner reported that formocresol wasboth mutagenic and carcinogenic.2 Part ofthe conclusion of their paper read: ‘Thereis a need to re-evaluate the rationale anduse of formocresol in dentistry’. Manypapers have been published on the subjectsince that time, yet the treatment continuesto be taught and practised.
The authors of this paper are therefore tobe congratulated for showing, in a carefullycontrolled experiment on 84 teeth in 52children, that virtually the same success inpulpotomy treatment can be obtained bythe careful use of calcium hydroxide.Eighty-four per cent of the formocresolgroup, and 77% of the calcium hydroxidegroup, were classed as clinically andradiographically successful at the end of
the research period. Papers submitted to scientific journals
are subject to peer review, a process whichmust remain confidential. Thus the reportsof the reviewers, their comments,questions and concerns, are never seen bythe journal reader. Providing a summary ofa paper is slightly different. Not only doesthe writer have the opportunity to précisthe paper for the busy clinician, but also topose questions which may be consideredby both the authors and the readers.
The essence of any pulp capping orpulpotomy procedure has to be themaintenance of a sterile field during andafter treatment. Bacterial contamination,especially via saliva, will certainlycompromise the prognosis. Yet again, as inso many aspects of restorative dentistry,the work of Kakehashi et al. is seminal.3
Thus there are two further aspects of thework reported in this paper that are ofconsiderable interest. First, were the resultsin any way related to those cases where itwas or was not possible to place a rubber
dam? And second, were they related to theprovision of either an amalgam or acompomer restoration, given the knownanti-bacterial properties and superiorcavity sealing of the latter?
As an endodontist and a parent, I sincerelyhope that this paper will be widely referredto, and will lead to the abandonment of anoutdated technique which has been calledinto question for so long.
P V Carrotte,Clinical Lecturer, University of Glasgow DentalHospital and School
1 Pashley B L, Myers D R, Pashley D H, WhitfordG M. Systemic distribution of 14C formalde-hyde from formocresol treated pulpotomysites. J Dent Res 1980; 59: 602-607.
2 Lewis B B, Chestner S H. Formaldehyde indentistry: a review of mutagenic and carcino-genic potential. J Am Dent Assoc 1981; 103:429-434.
3 Kakehashi S, Stanley H R, Fitzgerald R J. Theeffects of surgical exposures of dental pulps ingerm free and conventional laboratory rats.Oral Surg, Oral Med , Oral Pathology 1965; 20:340-349.
An investigation of primary molar vital pulp therapyAn investigation of the relative efficacy of Buckley’s Formocresol and calcium hydroxide in primary molar vital pulptherapy P. J. Waterhouse, J. H. Nunn and J.M. Whitworth Br Dent J 2000; 188: 32-36
In brief
• Buckley’s Formocresol (dilute solution) is presentlyadvocated for primary vital pulp therapy.
• Alternatives to formocresol have been sought, because ofits reported toxicity.
• In this study, calcium hydroxide powder (99% pure)appeared to be a suitable alternative to formocresol.However, the inclusion criteria used in this study werestringent.
• The authors recommend further comparative studies toconsolidate the data.
formocresol and 77% (27/35) treated with calcium hydroxidewere classed as clinically and radiographically successful at thecut-off date, December 1997, after a mean clinical review of 22.5months (range 6.1–38.5 months) and a mean radiographic reviewof 18.9 months (range 1.3–36.9 months).
ConclusionThis investigation confirms the clinical efficacy of a one-fifthdilution of Buckley’s Formocresol as an agent in pulp treatmentof cariously exposed, vital primary molar teeth. However,calcium hydroxide in its pure, powder form is a clinicallyacceptable alternative when combined with strict selectioncriteria for this method of restorative care. There was astatistically insignificant difference in successful clinical andradiological outcome between the two treatment groups. Successwas unrelated to the duration of time taken to achievehaemostasis and the presence or absence of bleeding afterplacement of the medicament.